Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib

被引：0
作者：
Chun-wei Xu
Wen-xian Wang
Yan-ping Chen
Yu Chen
Wei Liu
Li-hua Zhong
Fang-fang Chen
Wu Zhuang
Zheng-bo Song
Xiao-hui Chen
Yun-jian Huang
Yan-fang Guan
Xin Yi
Tang-feng Lv
Wei-feng Zhu
Jian-ping Lu
Xiao-jiang Wang
Yi Shi
Xian-dong Lin
Gang Chen
Yong Song
机构：
[1] Fujian Cancer Hospital,Department of Pathology
[2] Fujian Medical University Cancer Hospital,Department of Chemotherapy
[3] Zhejiang Cancer Hospital,Department of Medical Oncology
[4] Fujian Cancer Hospital,Department of Thoracic Surgery
[5] Fujian Medical University Cancer Hospital,Department of Respiratory Medicine
[6] Fujian Cancer Hospital,undefined
[7] Fujian Medical University Cancer Hospital,undefined
[8] Geneplus-Beijing,undefined
[9] Jinling Hospital,undefined
来源：
Journal of Translational Medicine | / 16卷
关键词：
NSCLC; ALK; VENTANA IHC; RT-PCR; NGS; Crizotinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Responses to Crizotinib therapy in five patients with non-small-cell lung cancer who tested FISH negative and Ventana immunohistochemistry positive for ALK fusions
    Huang, Jin-Lin
    Zeng, Jing
    Wang, Fang
    Huang, Qi-Tao
    Lu, Jia-Bin
    Li, Xiao-Mei
    Chen, Wei-Qiang
    Zhu, Chong-Mei
    Jin, Jie-Tian
    Lin, Su-Xia
    PERSONALIZED MEDICINE, 2017, 14 (02) : 99 - 107
  • [22] CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer
    Zhang, Meiling
    Wang, Qian
    Ding, Yan
    Wang, Guoqun
    Chu, Yunqian
    He, Xiang
    Wu, Xue
    Shao, Yang W.
    Lu, Kaihua
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) : 1792 - 1797
  • [23] ALK inhibitors and advanced non-small cell lung cancer (Review)
    Rossi, Antonio
    Maione, Paolo
    Sacco, Paola Claudia
    Sgambato, Assunta
    Casaluce, Francesca
    Ferrara, Marianna Luciana
    Palazzolo, Giovanni
    Ciardiello, Fortunato
    Gridelli, Cesare
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (02) : 499 - 508
  • [24] Comparison of Different ALK Tests in Non-Small Cell Lung Cancer (NSCLC) Patients before and after Crizotinib and Their Clinical Outcome
    Van der Wekken, Anthonie
    Hart, Nils T.
    Hiltermann, Thijo
    Timens, Wim
    Groen, Harrie
    Schuuring, Ed
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S378 - S378
  • [25] Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance
    Xu, Haiyan
    Yang, Guangjian
    Yang, Lu
    Yang, Yaning
    Ma, Di
    Li, Junling
    Hao, Xuezhi
    Xing, Puyuan
    Wang, Yan
    THORACIC CANCER, 2019, 10 (05) : 1096 - 1102
  • [26] Crizotinib: A targeted therapy in advanced ALK-positive non-small cell lung cancer
    Toffart, A. -C.
    Sakhri, L.
    Moro-Sibilot, D.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2013, 69 (02) : 111 - 116
  • [27] CRIZOTINIB FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A. J.
    Doebele, R. C.
    Camidge, D. R.
    Jimeno, A.
    DRUGS OF TODAY, 2012, 48 (04) : 271 - 282
  • [28] Crizotinib primary resistance overcome by ceritinib in a patient with ALK-rearranged non-small cell lung cancer
    Facchinetti, Francesco
    Caramella, Caroline
    Auger, Nathalie
    Planchard, David
    Adam, Julien
    Lacroix, Ludovic
    Remon, Jordi
    Massard, Christophe
    Soria, Jean-Charles
    Friboulet, Luc
    Besse, Benjamin
    TUMORI JOURNAL, 2016, 102 : S46 - S49
  • [29] PATTERNS OF RELAPSE AND PROGNOSIS AFTER CRIZOTINIB THERAPY FAILURE IN ALK plus NON-SMALL CELL LUNG CANCER
    Yanagitani, Noriko
    Nishizawa, Hironari
    Katayama, Ryohei
    Kobayashi, Hiroshi
    Gyotoku, Hiroshi
    Uenami, Takeshi
    Tambo, Yuichi
    Kudo, Keita
    Ohyanagi, Fumiyoshi
    Horiike, Atsushi
    Ninomiya, Hironori
    Motoi, Noriko
    Takeuchi, Kengo
    Ishikawa, Yuichi
    Fujita, Naoya
    Horai, Takeshi
    Nishio, Makoto
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1188 - S1188
  • [30] Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer
    Kang, Jin
    Chen, Hua-Jun
    Zhang, Xu-Chao
    Su, Jian
    Zhou, Qing
    Tu, Hai-Yan
    Wang, Zhen
    Wang, Bin-Chao
    Zhong, Wen-Zhao
    Yang, Xue-Ning
    Chen, Zhi-Hong
    Ding, Yan
    Wu, Xue
    Wang, Mei
    Fu, Jian-Gang
    Yang, Zhenfan
    Zhang, Xian
    Shao, Yang W.
    Wu, Yi-Long
    Yang, Jin-Ji
    THORACIC CANCER, 2018, 9 (09) : 1093 - 1103
12345